Literature DB >> 1737102

Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.

J Breton-Gorius1, P Clezardin, J Guichard, N Debili, L Malaval, W Vainchenker, E M Cramer, P D Delmas.   

Abstract

Osteonectin is a 32-Kd phosphoglycoprotein originally described in bone but also found in platelets. Platelet and bone osteonectin are different both structurally and immunologically. We have previously shown that platelet osteonectin, by binding to thrombospondin, is involved in the secretion-dependent phase of the platelet aggregation process. In this study, we used antiosteonectin antibodies in combination with immunogold labeling to investigate by electron microscopy the fine localization of osteonectin within normal and gray platelets. Using both a polyclonal and monoclonal antibody ON3, osteonectin was specifically located at the internal face of alpha-granule membranes within normal platelets. Osteonectin was not distributed within all alpha-granules, probably because of its low platelet content. In addition, using immunofluorescence, osteonectin could also be detected in immature and mature megakaryocytes with a granular pattern of staining, suggesting that osteonectin is synthesized by megakaryocytes. Using platelets from two patients with gray platelet syndrome, osteonectin was absent within all abnormal small alpha-granules, but was detected in some rare normal-sized alpha-granules. In separate double-label studies, thrombospondin and von Willebrand factor did not colocalize with osteonectin in resting platelets. However, osteonectin was located at the inner face of the alpha-granules, as it is for alpha-granule membrane protein GMP-140 and glycoprotein IIb-IIIa. These results, taken together with the fact that monoclonal antibodies to osteonectin bind only to the surface of activated platelets, suggest that platelet osteonectin is redistributed to the cell surface during fusion of alpha-granule membranes with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737102

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.

Authors:  David J Olivos; Marta Alvarez; Ying-Hua Cheng; Richard Adam Hooker; Wendy A Ciovacco; Monique Bethel; Haley McGough; Christopher Yim; Brahmananda R Chitteti; Pierre P Eleniste; Mark C Horowitz; Edward F Srour; Angela Bruzzaniti; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2017-04-18       Impact factor: 4.429

Review 2.  SPARC/osteonectin in mineralized tissue.

Authors:  Emilie M Rosset; Amy D Bradshaw
Journal:  Matrix Biol       Date:  2016-02-03       Impact factor: 11.583

3.  Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarction.

Authors:  V L Serebruany; D Atar; S R Murugesan; S Jerome; H Semaan; P A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

4.  A novel role for thrombopoietin in regulating osteoclast development in humans and mice.

Authors:  Monique Bethel; Calvin L T Barnes; Amanda F Taylor; Ying-Hua Cheng; Brahmananda R Chitteti; Mark C Horowitz; Angela Bruzzaniti; Edward F Srour; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-09       Impact factor: 6.384

5.  Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation.

Authors:  Wendy A Ciovacco; Ying-Hua Cheng; Mark C Horowitz; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

6.  Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation.

Authors:  Justin M Lemieux; Mark C Horowitz; Melissa A Kacena
Journal:  J Cell Biochem       Date:  2010-04-01       Impact factor: 4.429

7.  Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.

Authors:  M Slater; J Patava; R S Mason
Journal:  Experientia       Date:  1995-03-15

8.  GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice.

Authors:  Tomas E Meijome; R Adam Hooker; Ying-Hua Cheng; Whitney Walker; Mark C Horowitz; Robyn K Fuchs; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

Review 9.  Megakaryocytes in Bone Metastasis: Protection or Progression?

Authors:  Paola Maroni
Journal:  Cells       Date:  2019-02-08       Impact factor: 6.600

10.  Megakaryocytes promote bone formation through coupling osteogenesis with angiogenesis by secreting TGF-β1.

Authors:  Yong Tang; Mengjia Hu; Yang Xu; Fang Chen; Shilei Chen; Mo Chen; Yan Qi; Mingqiang Shen; Cheng Wang; Yukai Lu; Zihao Zhang; Hao Zeng; Yong Quan; Fengchao Wang; Yongping Su; Dongfeng Zeng; Song Wang; Junping Wang
Journal:  Theranostics       Date:  2020-01-12       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.